Published in Gene Therapy Weekly, April 22nd, 1996
Dr. Fred H. Gage of the Salk Institute and colleagues built on previous research in which "debilitated" HIV was combined with components of another virus to form efficient viral vectors. "Our results lend strong credence to the idea that HIV based vectors transduce genes efficiently and can be used for in vivo gene delivery," Gage said.
In the study Gage and his colleagues "... introduced the recombinant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.